Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center. Mediterr J Hematol Infect Dis 2026, 18 (1). https://doi.org/10.4084/MJHID.2026.044.